MedTrace Logo

Study for Cognitive and Genetic Characterization of a 45-65 Years Old Population

NCT01835717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2743

Last updated 2021-06-10

No results posted yet for this study

Summary

Before Alzheimer's disease (AD) clinical symptoms appear, there is a long period when changes in the brain occur. In this long asymptomatic period or preclinical phase, studies with populations at risk of developing AD have shown cognitive differences compared to control groups without such risk. There is a need for short, sensitive, easily administered, reproducible, non-expensive and independent of socio-demographic influences tests enabling the detection of pre-symptomatic variations in memory, when the memory decline is still within a normal range.

Study main hypothesis: When evaluated with high-demanding tests of memory and executive function, the cognitive performance of cognitive healthy people aged between 45 and 65 and, extensively, to a group of up to 75 years, will vary significantly depending on clinical, socio-demographic and genetic features

Conditions

  • Healthy Individuals

Sponsors & Collaborators

  • Obra Social La Caixa, Spain

    collaborator UNKNOWN

  • Barcelonabeta Brain Research Center, Pasqual Maragall Foundation

    lead OTHER

Principal Investigators

  • José Luis Molinuevo, MD, PhD · Barcelonabeta Brain Research Center, Pasqual Maragall Foundation

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2019-08-30
Completion
2020-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01835717 on ClinicalTrials.gov